Firm Novo Nordisk’s global patent is set to expire in parts of the world from early 2026, allowing cut-price ‘own-label’ ...

I N recent months makers of weight-loss drugs have gone on a crash diet. In late July Novo Nordisk, the Danish firm that gave ...

A new analysis found that semaglutide and tirzepatide offer great health benefits over a lifetime, but the immense scale of ...

Innovent Biologics' newly launched weight-loss drug is making inroads in its home market of China, ramping up competition ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Weight loss can be a challenge, even for those who eat ...

Pharmaceutical companies are racing to develop a GLP-1 weight-loss drug in pill form. Novo Nordisk says its oral semaglutide ...

Trial participants who received an increased weekly dose of Wegovy lost 19 per cent of their body weight in a year on average ...

Despite its dramatic ability to cut pounds by curbing appetite, high costs, unpleasant side effects, and health complications ...

Semaglutide (better known as Wegovy) may help people with obesity lose up to 25% of their body weight when used at a higher ...

Novo Nordisk A/S. Oral semaglutide 25 mg (the once-daily pill formulation of Wegovy ®) achieved significant weight loss, with ...

If you’re considering using medication to reach a healthy body weight, your first question might be: Are weight loss drugs ...

Higher doses of weight loss medications like Ozempic and Wegovy could help treat obesity. In two new studies, people taking 7 ...